Study Finds mRNA Vaccines Trigger T Cells via Muscle Cells, Not Just 1 Immune Route
Updated
Updated · Medscape · May 25
Study Finds mRNA Vaccines Trigger T Cells via Muscle Cells, Not Just 1 Immune Route
2 articles · Updated · Medscape · May 25
Summary
Nature Biotechnology data from mice showed mRNA vaccines still activated T cells when dendritic-cell expression was shut off, while blocking expression in muscle cells reduced the response.
T-cell activity tripled when liver-cell expression was turned off, suggesting liver cells can dampen immunity as muscle cells help drive it.
The findings challenge the long-held view that mRNA must enter dendritic cells directly, pointing instead to antigen handoff through cross-presentation or “cross-dressing” by nonimmune cells.
Related mouse work from Kenneth Murphy’s lab found partial mRNA-vaccine T-cell responses even without dendritic-cell MHC class I, reinforcing the idea that multiple presentation pathways operate at once.
That broader mechanism could help developers tune mRNA drugs differently—boosting CD8+ killer T cells for cancer vaccines or minimizing immune activation in genetic-disease therapies.
mRNA vaccines use a 'backdoor' through muscle cells to activate immunity. How will this unlock next-generation cancer therapies?
The liver actively suppresses mRNA vaccine responses. Can scientists now design 'stealth' therapies to treat genetic diseases without immune rejection?
Precision mRNA Vaccines: How Cell-Specific Targeting and Non-Immune Cells Are Redefining Immunity and Therapeutic Safety in 2026
Overview
Recent studies in 2026 have led to a major shift in our understanding of mRNA vaccines. Instead of only targeting professional immune cells, researchers found that non-immune cells like muscle and liver cells play key roles in the immune response. These non-immune cells produce vaccine antigens, which are then cross-presented by other cells to the immune system. This indirect pathway is now seen as a crucial reason why mRNA vaccines work so well. This new view expands how scientists think about antigen processing and opens up new ways to design more effective vaccines.